Adjuvant nivolumab after preoperative chemoradiotherapy and surgery in esophageal cancer: A shifting paradigm

J Thorac Cardiovasc Surg. 2022 Aug;164(2):433-437. doi: 10.1016/j.jtcvs.2021.08.082. Epub 2021 Sep 16.

¹ Division of Thoracic Surgery, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, Calif; Division of Thoracic Surgery, Department of Surgery and Perioperative Care, West Los Angeles VA Medical Center, Los Angeles, Calif. Electronic address: rcameron@stanfordalumni.org.
² Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Tex.
³ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

No abstract available

Keywords: adjuvant therapy; esophageal cancer; immune therapy; nivolumab; radiation; surgery; trimodality therapy.

Publication types